![Maria Klockare](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Maria Klockare
Corporate Officer/Principal chez Akinion Pharmaceuticals AB
Provenance du réseau au premier degré de Maria Klockare
Entité | Type d'entité | Industrie | |
---|---|---|---|
Akinion Pharmaceuticals AB
![]() Akinion Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Akinion Pharmaceuticals AB operates as a holding company that focuses on the development of pharmaceutical for the treatment of acute myeloid leukemia. It develops, markets, and sells a product based on Biovitrum’s anti leukemia kinase inhibitor research. It is a drug development that manufactures a lead candidate drug, AKN-028, which is a small molecule kinase inhibitor. The company was founded by Vendela Parrow in 2009 and is headquartered in Solna, Sweden.
12
| Holding Company | Pharmaceuticals: Major | 12 |
Axelar AB
![]() Axelar AB BiotechnologyHealth Technology Axelar AB operates as a biotechnology company. It aims to develop novel efficacious anti-cancer treatments. The company was founded by Erik Gustav Magnus Axelson and Lars Olov Larsson in 2003 and is headquartered in Solna, Sweden.
3
| Extinct | Biotechnology | 3 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Maria Klockare via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
The Wellcome Trust Ltd.
![]() The Wellcome Trust Ltd. Investment Trusts/Mutual FundsMiscellaneous The Wellcome Trust Ltd. engages welfare and charitable services. It supports the discovery of vaccines and drug-resistant infections, diversity and inclusion, open research, government investment in research, data sharing in public health emergencies, and strengthening ecosystems. The company was founded by Henry Wellcome in 1936 and is headquartered in London, UK. | Investment Trusts/Mutual Funds | Chief Executive Officer | |
TRUPOINT Partners, Inc.
![]() TRUPOINT Partners, Inc. Internet Software/ServicesTechnology Services TRUPOINT Partners, Inc. operates as regulatory compliance software and data analytics firm. Its solutions include compliance analytics software and consulting, regression analysis, branch Strategy and HMDA submission software. The company was founded in 2009 and is headquartered in Charlotte, NC. | Internet Software/Services | Director/Board Member | |
AstraZeneca AB
![]() AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Industrifonden
![]() Industrifonden Investment ManagersFinance Industrifonden is a Venture Capital firm, a subsidiary of Government of Sweden founded in 1979. The firm is headquartered in Stockholm. | Investment Managers | Private Equity Investor | |
Xention Pharma Ltd.
![]() Xention Pharma Ltd. Pharmaceuticals: MajorHealth Technology Xention Pharma Ltd. develops and researches drugs. The firm develops novel therapies for the treatment of atrial fibrillation; modulators of IKur and IKACh for atrial fibrillation. The company was founded by John W. Word and is headquartered in Newmarket, the United kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Wellcome Trust Technology Transfer
![]() Wellcome Trust Technology Transfer Investment ManagersFinance Wellcome Trust Technology Transfer (Wellcome Trust Technology Transfer) is a venture capital subsidiary of The Wellcome Trust Ltd. founded in 1992 by Graham Eric Fagg. The firm is headquartered in London. | Investment Managers | Founder | |
Babson College | College/University | Corporate Officer/Principal | |
GlaxoSmithKline, Inc.
![]() GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Stockholm School of Economics | College/University | Masters Business Admin | |
University of Uppsala | College/University | Graduate Degree Corporate Officer/Principal Doctorate Degree Graduate Degree | |
PainCeptor Pharma Corp.
![]() PainCeptor Pharma Corp. Pharmaceuticals: MajorHealth Technology PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada. | Pharmaceuticals: Major | Director/Board Member | |
ONCOPEPTIDES AB | Pharmaceuticals: Major | Director of Finance/CFO General Counsel Chief Tech/Sci/R&D Officer | |
University of Westminster | College/University | Masters Business Admin | |
University of Gothenburg | College/University | Doctorate Degree | |
Jönköping International Business School | College/University | Chief Executive Officer | |
Aprea Therapeutics AB
![]() Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | |
Ingenix Pharmaceutical Services, Inc.
![]() Ingenix Pharmaceutical Services, Inc. Packaged SoftwareTechnology Services Part of UnitedHealth Group, Inc., Ingenix Pharmaceutical Services, Inc. provides healthcare information technology and consulting services. The company is based in Basking Ridge, NJ. | Packaged Software | Corporate Officer/Principal | |
Swedish Orphan Biovitrum International AB
![]() Swedish Orphan Biovitrum International AB Pharmaceuticals: MajorHealth Technology Swedish Orphan Biovitrum International AB develops, manufactures, and sells pharmaceutical products and drugs. It offers patients and partners an international network specializing in the development, marketing and distribution of orphan drugs. The company is headquartered in Stockholm, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pergamum AB
![]() Pergamum AB Pharmaceuticals: MajorHealth Technology Pergamum AB develops, registers, markets, and trades pharmaceutical products based on therapeutic peptides. The company was founded on June 18, 2008 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Novartis Sverige AB
![]() Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Novartis Sverige AB trades pharmaceutical products. It offers products for the treatment of ADHD, multiple sclerosis, urticaria, allergic asthma, psoriasis, chronic obstructive pulmonary disorder, migraine, blood diseases, eye disorder, and other diseases. The company is headquartered in Kista, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Pfizer AB | Corporate Officer/Principal | ||
Almi Stockholm Investeringsfond AB
![]() Almi Stockholm Investeringsfond AB Finance/Rental/LeasingFinance Almi Stockholm Investeringsfond AB provides financing to small businesses in the early stages. It also offers financial advice to businesses. The company was founded on January 23, 1980 and is headquartered in Stockholm, Sweden. | Finance/Rental/Leasing | Comptroller/Controller/Auditor | |
ASARINA PHARMA AB | Pharmaceuticals: Major | Director/Board Member | |
ClanoTech AB
![]() ClanoTech AB Pharmaceuticals: MajorHealth Technology ClanoTech AB is a holding company that develops drugs for the treatment of cancer and macular degeneration. Its lead candidate is an inhibitor of the alpha5beta1-integrin receptor which is present in fibroblast and on vascular endothelial cells. Its Alpha5beta1-integrin is strongly up-regulated in fibroblast when switching to the fibrotic state and in scars after glaucoma surgery. Its strategy spans from therapeutic areas with high commercial potential as wet Age Regulated Macular Degeneration to ophthalmology niche indications with orphan drug opportunity such as developing advent in glaucoma surgery techniques. The company was founded by Yihai Cao in 2006 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | Director/Board Member Comptroller/Controller/Auditor Corporate Officer/Principal | |
Regman AB | Founder | ||
IPMI Business School | College/University | President | |
SPRINT BIOSCIENCE AB | Pharmaceuticals: Major | Director/Board Member | |
KAROLINSKA DEVELOPMENT AB | Financial Conglomerates | Chief Tech/Sci/R&D Officer Chairman | |
GUARD THERAPEUTICS INTERNATIONAL AB | Pharmaceuticals: Major | Director/Board Member | |
KDev Oncology AB
![]() KDev Oncology AB Miscellaneous Commercial ServicesCommercial Services KDev Oncology AB offers research and development of new cancer treatments. It provides know-how in the field of oncology. The company was founded by David Jern on July 14, 2005 and is headquartered in Solna, Sweden. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Chairman Chief Operating Officer Chief Executive Officer | |
Stockholm School of Entrepreneurship | College/University | Director/Board Member | |
Betagenon Sweden AB
![]() Betagenon Sweden AB Pharmaceuticals: MajorHealth Technology Betagenon AB engages in development of AMP-activated protein kinase (AMPK) activator compounds chronic energy balance disorders diseases. The company was founded by Helena Edlund, Thomas Edlund and Olof Karlsson and is headquartered in Umea, Sweden. | Pharmaceuticals: Major | Chief Operating Officer | |
OnTarget Chemistry AB
![]() OnTarget Chemistry AB BiotechnologyHealth Technology Part of Recipharm AB, OnTarget Chemistry AB provides research services for medicinal synthesis and pharmaceutical products. The company is based in Uppsala, Sweden. OnTarget Chemistry was acquired by Recipharm AB on June 15, 2015 for $1.85 million. | Biotechnology | Chief Executive Officer | |
Warner Lambert Nordic AB | Corporate Officer/Principal | ||
Immuneed AB
![]() Immuneed AB Medical SpecialtiesHealth Technology Immuneed AB develops drugs. The firm offers as a contract research organization and provides specialized services for immunotoxicology and immunophenotyping. Its services include cytokine release assay, complement activation, cellular drug biodistribution, cell activation patterns, immune recall responses, viability analyses, blood status and mode-of-action studies. The company was founded by Sara Mangsbo, Erika Fletcher and Thomas Totterman in 2014 and is headquartered in Uppsala, Sweden. | Medical Specialties | Director/Board Member | |
Accelerated Drug Development AB | Chairman | ||
SCI Innovation AB | Director/Board Member | ||
OT Lehmann Holding AB
![]() OT Lehmann Holding AB Investment Banks/BrokersFinance OT Lehmann Holding AB provides securities and property management services. The private company is based in Stockholm, Sweden. | Investment Banks/Brokers | Director/Board Member | |
Recipharm OT Chemistry AB
![]() Recipharm OT Chemistry AB Pharmaceuticals: MajorHealth Technology Part of Recipharm AB, Recipharm OT Chemistry AB develops and manufactures drug dosage forms and inhalation products & devices. The company is based in Uppsala, Sweden. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Synartro AB | Chairman | ||
EpiEndo Pharmaceuticals ehf
![]() EpiEndo Pharmaceuticals ehf BiotechnologyHealth Technology EpiEndo Pharmaceuticals ehf is a clinical-stage biopharmaceutical company based in Reykjavik, Iceland. The Icelander company focuses on enhancing epithelial barrier integrity to treat inflammatory disorders, with a primary focus on chronic respiratory diseases. The company recently appointed Dr. Kate Hanrott as Director of Clinical Operations and Sciences, bringing extensive experience to the role. EpiEndo Pharmaceuticals will be attending the Bio International Convention in June 2023. EpiEndo Pharmaceuticals was founded in 2014 by Fridrik Gardarsson, and Maria Bech has been the CEO of the company since 2021. | Biotechnology | Chief Executive Officer | |
OT Pharmaceuticals AB | Chief Executive Officer | ||
AnaCardio AB
![]() AnaCardio AB Pharmaceuticals: MajorHealth Technology AnaCardio AB is a clinical stage biopharmaceutical company based in Stockholm, Sweden. AnaCardio develops drugs targeting a novel mechanism that improves cardiac contractility to treat heart failure, a progressive cardiac syndrome affecting more than six million individuals in the US and nearly 100 million worldwide. The Swedish company's unique solution is based on the ghrelin signaling pathway, intended to increase contractility without causing adverse tachycardia, arrhythmia, ischemia, or hypotension. The company was founded by Lars Lund and is currently led by CEO Patrik Strömberg since 2021. | Pharmaceuticals: Major | Director/Board Member |
Statistiques
Internationale
Suède | 36 |
Etats-Unis | 6 |
Royaume-Uni | 5 |
Canada | 3 |
France | 2 |
Sectorielle
Health Technology | 25 |
Consumer Services | 9 |
Finance | 6 |
Commercial Services | 4 |
Technology Services | 3 |
Opérationnelle
Director/Board Member | 57 |
Corporate Officer/Principal | 44 |
Chairman | 26 |
Chief Executive Officer | 18 |
Chief Tech/Sci/R&D Officer | 13 |
Relations les plus connectées
- Bourse
- Insiders
- Maria Klockare
- Connexions Sociétés